To investigate the association between increased fetal nuchal translucency (NT) and maternal folate receptor alpha autoantibodies (FRAA) positivity, and to evaluate the subsequent risk of non‐syndromic autism spectrum disorder (ASD) in offspring. This evidence concerns the gene FOLR1 and autism spectrum disorder.